Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes.
Validation of a prognostic model and the impact of mutations in patients with lower-risk myelodysplastic syndromes. J Clin Oncol. 2012 Sep 20; 30(27):3376-82.